PAX1 and cervical cancer: In summary, PAX1 gene methylation status was a potential prognostic biomarker, our study innovatively studied the role of PAX1 in radioresistance and established a visual nomogram to predict the risk of residual tumor in patients with cervical cancer receiving radiotherapy.